Several novel quinazolino [3, 4-a] thieno [3, 2-d] pyrimidin-8-one derivatives were synthesized. All of the compounds were determined against MiaPaCa2 and DU145 cells in vitro, and the crystal structures of analog 8 and 20 in the active site of the EGFR complexes were presented. The entire compounds had been identified by 1 HNMR, 13 CNMR, IR, MS and EA. The quinazolones substructure has been found in many plant and microbial metabolites as part of complex molecules such as febrifugine, methaqualon, rutaecarpine, (-) vasicinone and luotonin A-F that possess a quinazolinone moiety and fuse with indolopyrido and pyrrolloquinoline ring systems, respectively (1-3). Mostof these molecules have pronounced biologic activities, and are used as fungicides, anti-inflammatory, anticancer, abirritant and antihypertensive agents (4-12). We report here the design, synthesis and antitumor activity of quinazolino [3, 4-a] thieno [3, 2-d] pyrimidin-8-one derivatives with different substituents at the position of the side chain, which also have quinazolones skeleton.
Results and DiscussionCytotoxicity The quinazolino [3, 4-a] thieno [3, 2-d] pyrimidin-8-one derivatives had been synthesized with different substituents at the position of the side chain, such as morpholine, N-methyl piperazidine, pyrrole and so on. The compounds, which have quinazolones skeleton, had been reported to block tumor growth, such as prostate cancer and pancreatic cancer ( a 13). This target compounds were determined against human prostate cancer DU145 and pancreatic cancer MiaPaCa2 cells in vitro, and the results are shown in (Table 1). It was found that the compounds with long side chain being at C3 position have more highly potent antitumor activity than which with long side chain being at C2 position. And most compounds have higher activity against MiaPaCa2 than DU145. Replacement of long side chain being at C2 position and C3 position with 2-methylpiperidine (e.g. compounds 13 and 20) resulted in a significant improvement in the selectivity versus DU145 and pancreatic cancer MiaPaCa2 cells. Diethylamine group was found to be particularly favorable in the long side chain being at C3 position (e.g. compound 11), while 4-methylpiperidine group in the long side chain being at C2 position (e.g. compound 19) gave rise to better antitumor activity. Diethylamine group was found to have poor antitumor activity in the long side chain being at C2 position (e.g. compound 18), but 2-methylpiperidinyl group in the long side chain being at C2 position led to a marked improvement in antitumor activity (e.g. compound 20). Replacement of 4-methylpiperidine group in compound 19 with 4-methylpiperazinyl (e.g. compound 15) provided a marked improvement in antitumor activity.In summary, we have developed a series of quinazolino [3, 4-a] thieno [3, 2-d] pyrimidin-8-one derivatives as novel antitumor agents.
DockingIn recent years, many compounds, which are structurally related to quinazolones, have been used as receptor tyrosine kinases inhibitors, such as gefitinib, er...